Replica project: degree at the University of Catania
The summer graduation session at the University of Catania was held last week. Among the works of the new graduates in the biotechnology degree courses are also two theses on…
CoEHAR interview: Attaullah Ahmadi
CoEHAR interview with prof. Attaullah Ahmadi, visiting researcher della French School of Public Health e Global Health Focus presso il Dipartimento di Medicina Clinica e Sperimentale dell'Università di Catania. https://www.youtube.com/watch?v=MeaAmfnw4WU
New seminar at CoEHAR on THR in Afghanistan
“TOBACCO HARM REDUCTION IN AFGHANISTAN: EXPERIENCES, CHALLENGES, AND RECOMMENDATIONS”, new seminar at CoEHAR, University of Catania. On Friday, 14th July 2023 at 12 am CEST, Room 6 in the Biological Tower, Dr.…
Just published the first randomized controlled trial of varenicline for vaping cessation
The use of the drug combined with an innovative vaping cessation counseling program was safe and effective for quitting e-cigarettes. The combined approach also decreased the chances of relapsing back to vaping and smoking.
Diasmoke Working Group in Warsaw: how to address the smoking issue among diabetes patients?
During the 2023 edition of the GFN, a pool of international diabetologists, coordinated by CoEHAR, addressed the issue of cigarette smoking among diabetes patients, setting new international treatment guidelines to be published soon.
VERITAS COHORT: the project takes off as 27 countries are involved all over the World
In May, CoEHAR has launched one of its most ambitious project, the Veritas Cohort study. Now, more than 400 people from 27 different countries are involved and numbers keep increasing.
At GFN 2023, SAB Diasmoke second meeting
GFN 2023 will start tomorrow at Varsavia. The 10th edition of the Global Forum on Nicotine, from 21 to 24 June, will host more events dedicated to harm reduction research. During this edition will be also the second meeting of SAB Diasmoke. Diabetologists and experts on THR signed the guidelines on the treatment of smokers with diabetes.
CoEHAR, UNIVERSITY OF CATANIA: HARM REDUCTION IS THE WEAPON TO DEFEAT SMOKE
“It is a fact that in Italy there are millions of smokers who are unwilling or unable to quit smoking – explained prof. Riccardo Polosa, founder of CoEHAR - These smokers do not accept to be medicalized because of their smoking habit and in Italy, even today, we do not have a health policy that takes care of these people. Risk reduction is the solution. In countries with a liberal approach, such as Sweden or England, which have chosen to open up to alternative nicotine release tools by promoting them in the cessation paths for heavy smokers, the prestigious smoke-free goal is being reached. It is time to follow these virtuous examples also in Italy".
ENDS 2023: CoEHAR at the European ecig conference, Amsterdam
Dr. Rosalia Emma will discuss the presentation “Inhalation preclinical assessment: In vitro science for real life user” during the panel dedicated to “Tackling concerns around industry standards”.
EU: public consultation on the “Evaluation of the legislative framework for tobacco control”
The European Commission has launched a public consultation on the "Evaluation of the legislative framework for tobacco control" which allows citizens, experts, industries and all stakeholders to express their opinion on the revision of the Tobacco Directive (TPD) through filling in a multiple-choice questionnaire, and sharing a final opinion of up to 500 characters.
